| |
Bulletin
Highlights
BCG
Welcomes Dr. Janice Wilson & Dr. Nebojsa Djordjevic
Spotlight
on Outsourcing
An
Early Look at FDA Regulation of Nanotechnology
The
Proof-of-Principle Alliance
Your
chance to meet with BCG representatives
|
|
BCG
Welcomes:
Janice M. Wilson,
Ph.D.
Nebojsa M. Djordjevic, Ph.D.
|
|
JANICE
M. WILSON, PH.D.
Dr.
Wilson joined the group in December 2007. She is a quality and compliance
executive with over 25 years of global and international experience
in the highly regulated bioscience industries. Dr. Wilson was most
recently the Global Head of Compliance for Novartis Vaccine and
Diagnostics working out of the Emeryville, CA office where she was
a member of the executive team providing oversight for the development
and implementation of the division's Quality Manual. Her experience
includes development, implementation, and directing of sustainable
Quality Systems, Quality Assurance programs, and extensive Regulatory
Compliance programs for GMP and ISO activities.
Read
Announcement
See
Curriculum Vitae
NEBOJSA
M. DJORDJEVIC, PH.D.
Dr.
Djordjevic joined BCG in January of 2008. Dr. Djordjevic has over
20 years of experience in Analytical Chemistry utilized in Pharmaceutical
and Biopharmaceutical Industry. During this time he has played an
active role at virtually every phase of drug development from target
identification, lead identification, compound selection and characterization,
and pharmaceutical product development. He was most recently the
Director of Analytical Chemistry at Cytokinetics Inc., a biopharmaceutical
company involved in the discovery and development of oncology and
cardiovascular drugs.
Read
Announcement
See
Curriculum Vitae
|
Spotlight
on Outsourcing
Articles
by
Michael Trapani, MS, MBA & David Pepperl, Ph.D.
Senior Consultants
|
|
The
November issue of RAPS Focus Magazine highlights Outsourcing and
includes contributions by both Michael Trapani, MS, MBA and David
Pepperl, Ph.D.
Quality
& Compliance: The Quality Agreement
Michael
Trapani, MS, MBA
Contact
Mr. Trapani...
Preclinical
Outsourcing in 2008: Key Considerations for Study Success
David Pepperl,
Ph.D.
Contact
Dr. Pepperl...
|
An
Early Look at FDA Regulation of Nanotechnology
Article
by
Stuart Portnoy, M.D., Sr. Medical Device Consultant
|
| Nanotechnology,
broadly defined, is the field of applied science whose unifying theme
is the fabrication of materials and products on the atomic and molecular
scale -- normally 1 to 100 nanometers (nms). There is currently a
wellspring of academic and private sector research and development
exploring the myriad potentials for nanotechnology to provide enhanced
performance of existing technologies (e.g., improved efficiency of
photovoltaic cells) and to offer novel solutions to historically vexing
problems (e.g., targeting chemotherapy drugs for release at tumor
sites while sparing healthy tissues).
Nanomedicine
Nanomedicine
is an area of biomedical research that seeks to use nanoscale tools
to improve health. Current medical uses of nanotechnology include
sunscreens, dental-bonding agents, novel wound dressings, and liposomal
drug delivery platforms.
Continue
Reading....
Contact
Dr. Portnoy...
|
The
Proof-of-Principle (POP) Alliance
|
|
Biologics
Consulting Group, Inc (BCG) has partnered with AVOS Life Sciences
to create the Proof-of-Principle Alliance (POP Alliance) to provide
fast track product development and commercialization/valuation consulting
services to early phase biopharmaceutical companies seeking to accelerate
the advancement of their products from the research and development
phase through a proof-of-principle clinical trial. See www.POPAllianceUSA.com
for additional information.
|
Upcoming
BCG Presentations
&
Conference Appearances
|
|
BCG
consultants attend numerous conferences every year during which
they are available to provide company information or consulting
expertise. Below are some conferences that BCG consultants will
be attending in the near future. Please feel free to contact the
attending consultant either before, or during the conference for
company information or to discuss a business opportunity.
|
|
Date
|
Sponsoring
Organization
|
Conference
and Presentation Title
|
BCG
Attendee(s)/ Speaker (s)
|
Location
|
| January
14 - 15, 2008 |
IBC
China |
US
FDA Biological Approval Process |
Lei
Zhang, MD, Ph.D.
(speaker) |
Seoul,
South Korea |
| January
14 - 16, 2008 |
ALS
Association |
ALSA
Research Workshop |
Wilson
W. Bryan, M.D.
(speaker)
|
Tampa,
FL |
| January
17 - 18, 2008 |
IBC
China |
US
FDA Biological Approval Process |
Lei
Zhang, MD, Ph.D.
(speaker) |
Taipei,
Taiwan |
| January
21-23, 2008 |
Institute
for International Research |
5th
Annual Formulation & Forced Degradation
"Implementation
of a flexible yet cGMP complaint Stability Program for Phase I,
II and III Studies"
|
Nanda
Subbaro, Ph.D.
(speaker) |
San
Diego, CA |
| January
27-30, 2008 |
CASSS |
CMC
Strategy Forum
Current
Practices for Assessing the Comparability and Stability of Gene
Therapy Products
|
Andra
Miller, Ph.D.
Maritza
C. McIntyte, Ph.D.
Nadine
Ritter, Ph.D.
(co-leader)
Darin Weber,
Ph.D.
|
Washington,
DC |
| January
27-30, 2008 |
CASSS |
CMC
Strategy Forum
Extractables
and Leachables: Challenges and Strategies in Biopharmaceutical Development
|
Keith
Wells, Ph.D.
Ruth Wolff, Ph.D.
|
Washington,
DC |
| January
27-30, 2008 |
CASSS |
CMC
Strategy Forum
12th
Annual Symposium on the Interface of Regulatory and Analytical Sciences
for Biotechnology Health Products
|
Nadine
Ritter, Ph.D.
(speaker)
Keith Wells,
Ph.D.
Ruth Wolff, Ph.D.
|
Washington,
DC |
| January
28-29, 2008 |
International
Pharamceutical Academy (IPA) |
FDA
Pre-Approval Inspections
"FDA
approval processes and combination device and biologics inspections"
|
John
R. Godshalk, MSE, MBA
(speaker) |
Toronto,
Canada |
| January
28-30, 2008 |
Phacilitate |
Phacilitate
Cell & Gene Therapy Forum 2008 |
Andra
Miller, Ph.D.
Maritza
C. McIntyte, Ph.D.
Darin
Weber, Ph.D.
|
Washington
DC |
| February
9-10, 2008 |
ISCTR
(International Society for Cardiovascular Translational Research) |
Annual
Meeting
"Regulatory
Considerations for Cell Manufacturing and Cell Delivery"
|
Darin
Weber, Ph.D.
(speaker) |
San
Diego, CA |
| February
21-22, 2008 |
Texas
Scottish Rite Hospital for Children |
30th
Annual Carrell-Krusen Neuromuscular Symposium |
Wilson
W. Bryan, M.D. |
Dallas,
TX |
| February
25-29, 2008 |
Seton
Hall Law School
|
Health
Care Compliance Certification Program
"Advertising
& Promotion of Medical Devices"
|
Stuart
Portnoy, MD
(speaker) |
Newark,
NJ |
| March
6-7, 2008 |
ASENT
(American Society of Experimental NeuroTherapeutics) |
Annual
Meeting |
Wilson
W. Bryan, MD
(course co-director) |
Washington,
DC |
| March
16-20, 2008 |
Society
of Toxicology |
SOT
Annual Meeting and Tox Expo |
John
Jessop, Ph.D., MPH |
Seattle,
WA |
| March
28-29, 2008 |
AABB
(American Association of Blood Banks) |
Spring
Conference 2008
Regulatory
Considerations of Using Stem Cells for Cardiac Applications
|
Ellen
M. Areman, MS, SBB
(speaker) |
Orlando,
FL |
|
|
|
|